Bruker Corporation to Host Investor Webinar on May 17, 2024

Rhea-AI Summary

Bruker (Nasdaq: BRKR) will host an Investor Webinar on May 17, 2024, to discuss recent acquisitions and provide a financial outlook. The webinar will feature presentations by company executives and leaders of the acquired businesses.

BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) today announced it intends to hold an Investor Webinar from 10 am to about 12 noon Eastern Daylight Time (EDT) on May 17, 2024, to provide additional insights into its three recent acquisitions of Chemspeed, ELITech, and of the NanoString business. Bruker also expects to provide an update to its medium-term financial outlook.

The Investor Webinar will include presentations by CEO Frank H. Laukien, CFO Gerald Herman, and by the leaders of these three new Bruker businesses, all followed by a live Q&A session for analysts and investors.

A link to the Investor Webinar will be available in the Events & Presentations section of the Company’s Investor Relations website at https://ir.bruker.com. A replay will be available on Bruker’s Investor Relations website after the conclusion of the event.

About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240509874955/en/

Justin Ward

Sr. Director, Investor Relations & Corporate Development

Bruker Corporation

T: +1 (978) 313-5800

E: Investor.Relations@bruker.com

Source: Bruker Corporation

FAQ

When will Bruker host the Investor Webinar?

Bruker will host the Investor Webinar on May 17, 2024.

What acquisitions will be discussed during the webinar?

Bruker will discuss the recent acquisitions of Chemspeed, ELITech, and the NanoString business.

Who will be presenting at the Investor Webinar?

CEO Frank H. Laukien, CFO Gerald Herman, and leaders of the acquired businesses will present at the webinar.

Where can I access the Investor Webinar link?

The Investor Webinar link will be available in the Events & Presentations section of Bruker 's Investor Relations website at https://ir.bruker.com.

Will there be a replay of the Investor Webinar?

Yes, a replay of the webinar will be available on Bruker 's Investor Relations website after the event.